CLINICAL TRIALS PROFILE FOR CORTROSYN

All Clinical Trials for Cortrosyn

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00462644 ↗	Evaluation of Etomidate on Adrenal Function in Trauma Patients	Completed	University of Tennessee	N/A	2006-02-01	Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitation following RSI in trauma patients.
NCT00484679 ↗	Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata	Completed	National Alopecia Areata Foundation	Phase 2	2007-05-01	The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands.
NCT00484679 ↗	Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata	Completed	University of Minnesota	Phase 2	2007-05-01	The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands.
NCT00484679 ↗	Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata	Completed	University of Minnesota - Clinical and Translational Science Institute	Phase 2	2007-05-01	The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands.
NCT00817219 ↗	Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris	Completed	LEO Pharma	Phase 2	2009-07-01	The purpose of this study is to evaluate the safety and efficacy of 4 weeks of TACLONEX ointment in adolescent patients with psoriasis vulgaris.
NCT01421797 ↗	Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation	Recruiting	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	N/A	2006-10-10	Women with polycystic ovary syndrome (PCOS) often have irregular menstrual periods, too much facial and body hair, and weight gain. Women with PCOS also have a hard time becoming pregnant. Girls with high levels of the male hormone testosterone often develop PCOS as adults. Some girls with high levels of male hormone will develop normal hormone levels as they grow up, but most girls continue to have high levels of male hormone as adults. The purpose of this study is to understand where the male and female hormones come from in girls as they get older. The investigators think the adrenal gland, makes most of the hormones in young girls and that the ovary and the adrenal gland make these hormones in older girls. The investigators would like to find out whether an overactive adrenal gland makes these hormones higher in girls who are overweight, compared to those who are not overweight.
NCT01421797 ↗	Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation	Recruiting	University of California, San Diego	N/A	2006-10-10	Women with polycystic ovary syndrome (PCOS) often have irregular menstrual periods, too much facial and body hair, and weight gain. Women with PCOS also have a hard time becoming pregnant. Girls with high levels of the male hormone testosterone often develop PCOS as adults. Some girls with high levels of male hormone will develop normal hormone levels as they grow up, but most girls continue to have high levels of male hormone as adults. The purpose of this study is to understand where the male and female hormones come from in girls as they get older. The investigators think the adrenal gland, makes most of the hormones in young girls and that the ovary and the adrenal gland make these hormones in older girls. The investigators would like to find out whether an overactive adrenal gland makes these hormones higher in girls who are overweight, compared to those who are not overweight.

Clinical Trial Conditions for Cortrosyn

Condition Name

Condition Name for Cortrosyn
Intervention	Trials
Hyperandrogenemia	1
Obesity	1
Polycystic Ovary Syndrome	1
Postural Tachycardia Syndrome	1

Condition MeSH

Condition MeSH for Cortrosyn
Intervention	Trials
Alopecia	1
Tachycardia	1
Adrenal Insufficiency	1
Syndrome	1

Clinical Trial Locations for Cortrosyn

Trials by Country

Trials by Country for Cortrosyn
Location	Trials
United States	11

Trials by US State

Trials by US State for Cortrosyn
Location	Trials
Tennessee	2
Virginia	2
Minnesota	1
Michigan	1
Washington	1

Clinical Trial Progress for Cortrosyn

Clinical Trial Phase

Clinical Trial Phase for Cortrosyn
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	2
Phase 1	1

Clinical Trial Status

Clinical Trial Status for Cortrosyn
Clinical Trial Phase	Trials
Completed	5
Recruiting	1
Active, not recruiting	1

Clinical Trial Sponsors for Cortrosyn

Sponsor Name

Sponsor Name for Cortrosyn
Sponsor	Trials
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	1
University of Minnesota - Clinical and Translational Science Institute	1
LEO Pharma	1

Sponsor Type

Sponsor Type for Cortrosyn
Sponsor	Trials
Other	10
NIH	3
Industry	1